vs
Side-by-side financial comparison of BLACKLINE, INC. (BL) and Sezzle Inc. (SEZL). Click either name above to swap in a different company.
BLACKLINE, INC. is the larger business by last-quarter revenue ($183.2M vs $135.5M, roughly 1.4× Sezzle Inc.). Sezzle Inc. runs the higher net margin — 37.9% vs 2.7%, a 35.2% gap on every dollar of revenue. On growth, Sezzle Inc. posted the faster year-over-year revenue change (29.2% vs 8.1%). Over the past eight quarters, Sezzle Inc.'s revenue compounded faster (111.9% CAGR vs 7.9%).
BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.
Sezzle is a publicly traded financial technology company headquartered in Minneapolis, U.S, with operations in the United States and Canada. The company provides an alternative payment platform offering interest-free installment plans at selected online stores. As of June 2021, the Sezzle platform had over 10 million user sign-ups and over 48,000 participating merchants.
BL vs SEZL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $183.2M | $135.5M |
| Net Profit | $4.9M | $51.3M |
| Gross Margin | 75.2% | — |
| Operating Margin | 3.7% | 50.9% |
| Net Margin | 2.7% | 37.9% |
| Revenue YoY | 8.1% | 29.2% |
| Net Profit YoY | -91.3% | 41.9% |
| EPS (diluted) | $0.07 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $135.5M | ||
| Q4 25 | $183.2M | $78.2M | ||
| Q3 25 | $178.3M | $57.5M | ||
| Q2 25 | $172.0M | $52.0M | ||
| Q1 25 | $166.9M | $48.2M | ||
| Q4 24 | $169.5M | $48.4M | ||
| Q3 24 | $165.9M | $35.6M | ||
| Q2 24 | $160.5M | $30.2M |
| Q1 26 | — | $51.3M | ||
| Q4 25 | $4.9M | $42.7M | ||
| Q3 25 | $5.3M | $26.7M | ||
| Q2 25 | $8.3M | $27.6M | ||
| Q1 25 | $6.1M | $36.2M | ||
| Q4 24 | $56.4M | $25.4M | ||
| Q3 24 | $17.2M | $15.4M | ||
| Q2 24 | $76.7M | $29.7M |
| Q1 26 | — | — | ||
| Q4 25 | 75.2% | — | ||
| Q3 25 | 75.1% | — | ||
| Q2 25 | 75.2% | — | ||
| Q1 25 | 75.5% | — | ||
| Q4 24 | 75.6% | — | ||
| Q3 24 | 75.2% | — | ||
| Q2 24 | 74.9% | — |
| Q1 26 | — | 50.9% | ||
| Q4 25 | 3.7% | 70.6% | ||
| Q3 25 | 4.3% | 61.9% | ||
| Q2 25 | 4.4% | 69.4% | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 3.7% | 63.8% | ||
| Q3 24 | 5.0% | 58.6% | ||
| Q2 24 | 1.4% | 55.3% |
| Q1 26 | — | 37.9% | ||
| Q4 25 | 2.7% | 54.6% | ||
| Q3 25 | 3.0% | 46.4% | ||
| Q2 25 | 4.8% | 53.1% | ||
| Q1 25 | 3.6% | 75.1% | ||
| Q4 24 | 33.3% | 52.4% | ||
| Q3 24 | 10.4% | 43.4% | ||
| Q2 24 | 47.8% | 98.4% |
| Q1 26 | — | — | ||
| Q4 25 | $0.07 | $1.19 | ||
| Q3 25 | $0.09 | $0.75 | ||
| Q2 25 | $0.13 | $0.78 | ||
| Q1 25 | $0.10 | $1.00 | ||
| Q4 24 | $0.79 | $0.71 | ||
| Q3 24 | $0.27 | $0.44 | ||
| Q2 24 | $0.22 | $0.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $390.0M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $332.3M | $196.7M |
| Total Assets | $1.8B | $454.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $390.0M | $64.1M | ||
| Q3 25 | $419.9M | $104.1M | ||
| Q2 25 | $459.1M | $88.9M | ||
| Q1 25 | $479.5M | $88.9M | ||
| Q4 24 | $885.9M | $73.2M | ||
| Q3 24 | $725.3M | $80.1M | ||
| Q2 24 | $616.6M | $58.0M |
| Q1 26 | — | $196.7M | ||
| Q4 25 | $332.3M | $169.8M | ||
| Q3 25 | $328.3M | $155.3M | ||
| Q2 25 | $414.0M | $130.4M | ||
| Q1 25 | $417.9M | $125.8M | ||
| Q4 24 | $446.7M | $87.8M | ||
| Q3 24 | $367.9M | $61.1M | ||
| Q2 24 | $325.8M | $50.3M |
| Q1 26 | — | $454.3M | ||
| Q4 25 | $1.8B | $400.2M | ||
| Q3 25 | $1.7B | $367.0M | ||
| Q2 25 | $1.8B | $350.6M | ||
| Q1 25 | $1.8B | $298.1M | ||
| Q4 24 | $1.8B | $298.4M | ||
| Q3 24 | $1.7B | $252.9M | ||
| Q2 24 | $1.9B | $212.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $26.7M | — |
| Free Cash FlowOCF − Capex | $26.1M | — |
| FCF MarginFCF / Revenue | 14.2% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 5.46× | — |
| TTM Free Cash FlowTrailing 4 quarters | $161.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $26.7M | $70.6M | ||
| Q3 25 | $63.8M | $63.7M | ||
| Q2 25 | $32.3M | $23.1M | ||
| Q1 25 | $46.7M | $52.5M | ||
| Q4 24 | $43.8M | $57.4M | ||
| Q3 24 | $55.9M | $35.1M | ||
| Q2 24 | $40.7M | $22.2M |
| Q1 26 | — | — | ||
| Q4 25 | $26.1M | $70.6M | ||
| Q3 25 | $63.3M | $63.6M | ||
| Q2 25 | $31.4M | $22.7M | ||
| Q1 25 | $40.8M | $52.5M | ||
| Q4 24 | $43.0M | $57.4M | ||
| Q3 24 | $55.5M | $35.1M | ||
| Q2 24 | $40.0M | $22.2M |
| Q1 26 | — | — | ||
| Q4 25 | 14.2% | 90.2% | ||
| Q3 25 | 35.5% | 110.6% | ||
| Q2 25 | 18.2% | 43.6% | ||
| Q1 25 | 24.4% | 108.9% | ||
| Q4 24 | 25.4% | 118.5% | ||
| Q3 24 | 33.5% | 98.6% | ||
| Q2 24 | 24.9% | 73.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 0.1% | ||
| Q3 25 | 0.3% | 0.3% | ||
| Q2 25 | 0.6% | 0.8% | ||
| Q1 25 | 3.6% | 0.1% | ||
| Q4 24 | 0.4% | 0.1% | ||
| Q3 24 | 0.2% | 0.0% | ||
| Q2 24 | 0.4% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 5.46× | 1.65× | ||
| Q3 25 | 12.07× | 2.39× | ||
| Q2 25 | 3.90× | 0.84× | ||
| Q1 25 | 7.72× | 1.45× | ||
| Q4 24 | 0.78× | 2.26× | ||
| Q3 24 | 3.24× | 2.27× | ||
| Q2 24 | 0.53× | 0.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BL
| Subscription And Circulation | $173.2M | 95% |
| Technology Service | $10.0M | 5% |
SEZL
Segment breakdown not available.